More specifically, ChIP-sequencing (ChIP-seq) revealed binding of MYCN to the EIF4EBP1 promoter in NB cells, and MYCN was reported to impact EIF4EBP1 transcription, pointing to EIF4EBP1 as a potential MYCN target gene [41, 42]. This evidence concerns the gene MYCN and neuroblastoma.